Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases. Its drugs are used for the treatment of lymphomas, leukemia blood cancers, rheumatoid arthritis, and various diseases resulting in vision impairment in adults.